First Report Customer Care 
All time: 4.6

Latest / Last 30 Days: 5.0

527 Reviews

Credit Rating - DENBOND PHARMACEUTICALS LIMITED

ANALYSIS
Credit Risk Update: SECURED CREDITOR INFORMATION: DENBOND PHARMACEUTICALS LIMITED, AMBA HOUSE, 4TH FLOOR, 15 COLLEGE ROAD, HARROW, MIDDLESEX, HA1 1BA. The legal status is a Private Limited Company and the current status at the registry of companies is Active. The last filed accounts are dated 30 September 2023. The company was incorporated on 5 July 1976.

The accounts next due date is 24 June 2025. There are 6 mortgages, 1 satisfied, none part satisfied and 5 unsatisfied.

The above was based on public record information as at 6 November 2024 and may not reflect the current status. Please access the current report to ascertain the current status and credit rating.
SUMMARY
Registered Number: 01267027
Date Incorporated: 5 July 1976
Date Latest Accounts: 30 September 2023
BUSINESS INFORMATION
Legal Form: Private Limited Company
Previous Names: None
Registered Number: 01267027
Annual Return: 30 September 2015
Registered Office: AMBA HOUSE, 4TH FLOOR, 15 COLLEGE ROAD, HARROW, MIDDLESEX, HA1 1BA
SIC Code and Operations: 46450
SECURED CREDITORS
Number of Mortgages 6
Satisfied Mortgages 1
Part Satisfied Mortgages 0
Unsatisfied Mortgages 5
CREDIT RISK RATING
This is the credit risk assessment used by one of the top UK credit reference agencies.
Risk Score (1-100):

DENBOND PHARMACEUTICALS LIMITED

Click Here

to view this information

Risk Assessment:
Credit Rating:



First Report Score: (0-10):

Financial Status Guide:
10  trafficlight Very Strong
9   Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical
Report Created On 16 November 2024 Copyright © 2024 First Report Ltd


Recent Searches

Reg No. Reg Name Status
12849865 DENBOR LIMITED Active
11448676 DENBORD LIMITED Active - Proposal to Strike off
13457945 DENBOREI SOLUTIONS LTD Active
08034940 DENBORELLA LIMITED Dissolved
02486233 DENBORNE LIMITED Active

In using this service you agree to the Terms and Conditions

© 2024 First Report Ltd